Seattle Genetics reported $0 in Debt for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Debt Change
Agios Pharmaceuticals AGIO:US $ 0.61M 0.2M
Bayer BAYN:GR € 40872M 894M
Daiichi Sankyo 4568:JP Y 163554M 93M
Eisai 4523:JP Y 89921M 9M
Genmab GEN:DC DK 416M 9M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 31025M 3218M
Teva Pharmaceutical TEVA:IT 23.04B 703M